Sun Pharma to acquire Innovcare Lifesciences for $28.7m
Sun Pharma expects to close the acquisition on or before 31 July 2026.
Drug Development
Japan approves Sanofi’s Sarclisa combo for MM treatment
Voro and Alloy partner on tumour-selective TCE therapeutics
Biogen to acquire RayThera for up to $1bn
Jazz and AbCellera sign deal for T-cell engagers in solid tumours
LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs
AviadoBio broadens vMiX gene silencing licence with King’s College London
Zai Lab’s zocilurtatug pelitecan secures EMA orphan drug status
